TOLDBODGADE 33, 1253 COPENHAGEN K, G7
Resolution Adopted at the Extraordinary General Meeting Including Grant of Restricted Stock Units to Board Members
Epcoritamab and R-CHOP Improve Survival in Lymphoma Patients
Major Shareholder Announcement
Reports Foreign Private Issuer Results for September 2026
Grant of Restricted Stock Units and Warrants to Employees in Company Announcement
Files Report on Form 6-K for September 2026
Capital Increase as a Result of Employee Warrant Exercise
To Hold Extraordinary General Meeting on October 7, 2026
Annual and Transition Report of Foreign Private Issuers
Registration Statement for Securities to be Offered to Employees
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Effectiveness Notice
No filings found
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Amended Tender Offer Statement by Third Party
Registration Statement for Depositary Shares
Registration Statement for Depositary Shares, Issued upon Effectiveness
Registration Statement for Additional Securities of Certain Foreign Private Issuers, Filed Pursuant to Rule 462(b)